Transfusion-Associated Microchimerism in Previously Injured Individuals Who Received a Blood Transfusion

Sponsor
National Heart, Lung, and Blood Institute (NHLBI) (NIH)
Overall Status
Terminated
CT.gov ID
NCT00441779
Collaborator
(none)
59
1
38
1.6

Study Details

Study Description

Brief Summary

Blood transfusions are frequently necessary in situations in which there is a large amount of blood loss. In some individuals who receive a blood transfusion, white blood cells from the donor's blood may remain in the body for years, a condition known as microchimerism. This study will evaluate the occurrence of microchimerism among the following three groups of individuals who previously received transfusions: 1) individuals with traumatic injuries; 2) individuals with burn injuries; and 3) individuals who underwent elective orthopedic operations.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Approximately 10% to 15% of injured patients who receive blood transfusions experience a condition known as transfusion-associated microchimerism. This occurs when white blood cells, or leukocytes, from the donor's blood persist in the recipient long after the transfusion occurs. The genetically distinct donor cells can remain in the individual for decades, and may account for as many as 4% of the white blood cells in the recipient's body. This suggests that the donor cells are tolerated by the recipient's immune system. The purpose of this study is to compare the incidence of microchimerism among individuals with three different types of injuries: 1) traumatic injuries; 2) thermal, or burn, injuries; and 3) injuries resulting from elective orthopedic surgical procedures.

    In this study, blood samples will be collected from individuals who were treated for traumatic injury, thermal injury, or elective orthopedic surgical procedures at the University of California at Davis Medical Center. Individuals who were treated from 2000 to 2003 and received a blood transfusion, as well as a control group of individuals who did not receive a transfusion, will be approached to enroll in the study. Individuals who agree to participate will have their blood analyzed for evidence of microchimerism. Information on health status, injury characteristics, hospital care, blood transfusion details, and blood donor characteristics will be collected from all participants.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    59 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Retrospective Study of the Prevalence of Transfusion-Associated Microchimerism Following Traumatic Injury, Burns, and Elective Orthopedic Procedures
    Study Start Date :
    Aug 1, 2008
    Actual Primary Completion Date :
    Oct 1, 2011
    Actual Study Completion Date :
    Oct 1, 2011

    Arms and Interventions

    Arm Intervention/Treatment
    1

    Traumatic injury

    2

    Elective orthopedic surgery

    3

    Burn injury

    Outcome Measures

    Primary Outcome Measures

    1. Microchimerism [5-11 years after transfusion]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    8 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Hospitalized for traumatic injury, thermal injury, or an elective orthopedic surgical procedure from 2000 to 2003 at the University of California at Davis Medical Center

    • Received at least 1 unit of transfused red blood cells

    Exclusion Criteria:
    • Currently incarcerated

    • Inadequate decision-making capacity of the participant and no available surrogate decision-maker

    • Prior bone marrow or solid organ transplantation

    • Prior blood transfusion other than at the time of hospitalization

    • Any history of an autoimmune disorder prior to hospitalization

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of California, Davis, Medical Center Sacramento California United States 95817

    Sponsors and Collaborators

    • National Heart, Lung, and Blood Institute (NHLBI)

    Investigators

    • Principal Investigator: Michael P. Busch, MD, PhD, Blood Systems Research Institute

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    National Heart, Lung, and Blood Institute (NHLBI)
    ClinicalTrials.gov Identifier:
    NCT00441779
    Other Study ID Numbers:
    • 1378
    • 1R01HL083388
    First Posted:
    Mar 1, 2007
    Last Update Posted:
    Jul 12, 2016
    Last Verified:
    Oct 1, 2014
    Keywords provided by National Heart, Lung, and Blood Institute (NHLBI)
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 12, 2016